<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00322062</url>
  </required_header>
  <id_info>
    <org_study_id>NRL994-02/2001</org_study_id>
    <nct_id>NCT00322062</nct_id>
  </id_info>
  <brief_title>MOVIPREP® Versus NaP Pivotal Phase III Study</brief_title>
  <official_title>A Prospective Randomised Single-Blinded Multicentric and Pivotal Phase III Study Comparing the Efficacy, Safety and Acceptability of a New 2 Litres Gut Lavage Solution NRL994 Versus a Sodium Phosphate Solution for Colonoscopy Preparation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Norgine</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Norgine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to compare a new 2 litre bowel cleansing product versus a sodium
      phosphate solution already on the market. Efficacy of each bowel preparation, safety and
      acceptability will be assessed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multicentric (15 centres), prospective, randomised, single-blinded phase III pivotal study in
      patients undergoing a colonoscopy. Gut cleansing will be performed using 2 litres of NRL994
      gut lavage solution with 1 litre (or more) of extra clear liquids or 2 x 45 ml of a sodium
      phosphate solution plus 2 litres (or more) of extra clear liquids the day before colonoscopy.
      Patients requiring a morning colonoscopy who fulfil the inclusion criteria, will be
      randomised. One of the two tested products will be delivered by a pharmacist, blindly from
      the gastroenterologist. The assigned product will be taken the day before the coloscopy
      according to the information leaflet. Efficacy of the two tested preparations will be
      measured on video-tape record of each colonoscopy by a final grading i.e. &quot;the overall
      quality of colonoscopy prep&quot; by an gastroenterologist expert. A standardised patient
      questionnaire administered by a nurse on the morning before colonoscopy will assess clinical
      tolerance and acceptability (satisfaction) of the prep. A baseline blood sampling will be
      withdrew before intake of the preparation and one more blood sample will be performed after
      the intake on the morning, before the coloscopy.

      After the coloscopy, as the gastroenterologist gives the result of the coloscopy , a last
      visit is performed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2002</start_date>
  <completion_date>March 2003</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>efficacy will be measured and graded using video-taped record of each colonoscopy for cleansing in a 0 - 4 grade scale for each of the predefined colon areas by an endoscopist.</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Grades A or B means a good or correct preparation and are considered as a success whilst C or D are considered as a failed preparation.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>evaluation of the preparation quality using a visual analogue scale</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>recording adverse events and clinical tolerance</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">340</enrollment>
  <condition>Colonoscopy</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 pack (contains 4 (2 x PEG + E/&quot;P&quot; + 2 x Vitamin C/&quot;C&quot;) sachets)= 2L NRL994 . 2 sachets (one of each) will be dissolved in 1L of water. Each litre will be drunk within 1 hour. Furthermore, at least 1000ml (or more) of any additional clear fluid (except milk) has to be drunk after the 2L of NRL994.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 pack consists of 2 flasks of 45ml. Each flask has to be dissolved within 125ml of water. Each intake of NaP solution has to be preceded and followed by 250ml (or more if necessary)of clear liquids(excluding milk)and a delay of at least 12 hours between the intake of the 2 x 45ml of NaP solution has to be completed. In addition, 750ml more of clear liquids (excluding milk)or more if needed must be drunk between the 2 intakes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate</intervention_name>
    <description>2L gut lavage solution</description>
    <arm_group_label>1</arm_group_label>
    <other_name>MOVIPREP®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium Phosphate Solution</intervention_name>
    <description>1 x 45ml solution, BID</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Fleet Phospho Soda®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male or female, out and inpatients to be at least 18 years old and &lt;75 years old sent
             to the endoscopic ward for diagnostic or therapeutic colonoscopy

          -  willing and able to complete the entire procedure and to comply with study
             instructions

          -  females of childbearing potential must employ an adequate method of contraception.

        Exclusion Criteria:

          -  age &lt;18 or &gt; 75 years old

          -  ileus

          -  suspected intestinal occlusion or perforation

          -  toxic or congenital megacolon

          -  history of colonic resection

          -  patients with Crohn's disease or ulcerative colitis

          -  congestive heart failure NYHA III or IV

          -  documented renal insufficiency history with creatinine &gt;170µmol/l

          -  known hypersensitivity to polyethylene glycols or Na phosphate and/or vitamin C

          -  concurrent participation in an investigational drug study or participation within 90
             days of study entry

          -  females who are pregnant, or planning a pregnancy. Females of childbearing potential
             not using reliable methods of contraception

          -  subject has a condition or is in a situation which in the investigators opinion may
             put the subject at significant risk, may confound the study results, or may interfere
             significantly
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alain Bitoun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Lariboisère</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital Jean Minjoz</name>
      <address>
        <city>Besancon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Mourier</name>
      <address>
        <city>Colombes</city>
        <zip>92700</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Huriez</name>
      <address>
        <city>Lille cedex</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Dupuytren</name>
      <address>
        <city>Limoges</city>
        <zip>87000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Edouard Herriot</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Nord</name>
      <address>
        <city>Marseille Nord cedex 20</city>
        <zip>13915</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier</name>
      <address>
        <city>Montelimar cedex</city>
        <zip>26216</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Intercommunal</name>
      <address>
        <city>Montfermeil</city>
        <zip>93370</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier De Montpellier Hôpital St Eloi</name>
      <address>
        <city>Montpellier</city>
        <zip>34000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital De L'Archet</name>
      <address>
        <city>Nice cedex 3</city>
        <zip>06202</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Unité Endoscopies Digestives, Hôpital Lariboisière, 2 rue Ambroise Paré</name>
      <address>
        <city>Paris cedex 10</city>
        <zip>75475</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Cochin</name>
      <address>
        <city>Paris cedex 14</city>
        <zip>75379</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Bichat Claude Bernard</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Croix Saint Simon</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Civil / Clinique Medical B</name>
      <address>
        <city>Strasbourg cedex</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Rangueil</name>
      <address>
        <city>Toulouse</city>
        <zip>31403</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Trousseau CHRU</name>
      <address>
        <city>Tours</city>
        <zip>37000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU De Brabois</name>
      <address>
        <city>Vandoeuvre Les Nancy Cedex</city>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Fordtran JS, Santa Ana CA, Cleveland MvB. A low-sodium solution for gastrointestinal lavage. Gastroenterology. 1990 Jan;98(1):11-6.</citation>
    <PMID>2293568</PMID>
  </reference>
  <verification_date>April 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 2, 2006</study_first_submitted>
  <study_first_submitted_qc>May 2, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2006</study_first_posted>
  <last_update_submitted>April 15, 2008</last_update_submitted>
  <last_update_submitted_qc>April 15, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 16, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dr Marc Halphen</name_title>
    <organization>Norgine</organization>
  </responsible_party>
  <keyword>Colon cleansing</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Polyethylene glycol 3350</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

